BUSINESS MODEL
Cebert Pharmaceuticals, Inc.
is a privately-held company that operates on sound business practices. Initially, Cebert partnered with institutional investors to fund operations as well as product acquisition and development opportunities.
In May, 2000, Cebert Pharmaceuticals redeemed all preferred shares belonging to the institutional investors and downsized to become a
lean, efficient, profitable organization. Since 2001, Cebert has acquired, licensed and developed products through strategic planning
to maintain profitablility.
With the 2009 divestiture of the Methadone product group to Roxane Labs/Boehringer Ingelheim, Cebert has invested in the development of products for women's health needs. Plans are to launch menoMEGATM, a vitamin for menopausal and post menopausal women and preMEGATM, a prenatal vitamin in the Fall of 2010 with additional products coming in 2011.
